Results
|
1.
|
|
|
2.
|
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naive chronic lymphocytic leukemia: a phase 2 study. MedStar authors:
Year: 2021
Citation: - Leukemia & Lymphoma. 62(8):1816-1827, 2021 08.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ahn IE, Desai S, Drinkwater DC, Farooqui MZ, Gaglione EM, Herman SEM, Hughes TE, Lindorfer MA, Lotter J, Maric I, Marti GE, Mo C, Nichols C, Nierman P, Pleyer C, Soto S, Stetler-Stevenson M, Sun C, Superata J, Taylor RP, Tian X, Valdez J, Wake L, Wiestner A, Yuan CM
|
|
3.
|
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma. MedStar authors:
- Al-Refaie, Waddah B
- Petronic-Rosic, Vesna
- Radfar, Arash
- Zaemes, Jacob
Year: 2021
Citation: - Journal for Immunotherapy of Cancer. 9(10), 2021 10.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Dermatology
- Internal Medicine Residency
- MedStar Georgetown University Hospital
Medline publication type:
All authors: - Al-Refaie WB, Atkins MB, Gardner K, Gibney GT, Petronic-Rosic V, Radfar A, Rapisuwon S, Reilly MJ, Shah NJ, Shand S, Swoboda D, Zaemes J
|
|
4.
|
|
|
5.
|
|